5332
A. T. Khan et al. / Tetrahedron Letters 52 (2011) 5327–5332
Chem. 1992, 35, 2735; (b) Patil, A. D.; Freyer, A. J.; Eggleston, D. S.;
Acknowledgments
Waltiwanger, R. C.; Bean, M. F.; Taylor, P. B.; Caranfa, M. J.; Breen, A. L.;
Bartus, H. R.; Johnson, R. K.; Hertzberg, R. P.; Westley, J. W. J. Med. Chem. 1993,
36, 4131.
M.L. is thankful to CSIR, New Delhi for his research fellowship.
S.A. and M.M.K acknowledge UGC, New Delhi for their research
fellowships. The authors are grateful to the Department of Science
and Technology for providing single XRD facility under FIST pro-
gram as well as to the Director, IIT Guwahati for providing general
facility. We are also grateful to the referees for their valuable
comments and constructive suggestions.
11. (a) Foye, W. O. Principi di Chemico Farmaceutica; Piccin: Padora, Italy, 1991. P
416.; (b) Andreani, L. L.; Lapi, E. Bull. Chim. Farm. 1960, 99, 583; (c) Zhang, Y. L.;
Chen, B. Z.; Zheng, K. Q.; Xu, M. L.; Lei, X. H.; Yaoxue, X. B. Chem. Abstr. 1982, 17,
17. Chem. Abstr. 1982, 96, 135383e; (d) Bonsignore, L.; Loy, G.; Secci, D.;
zCalignano, A. Eur. J. Med. Chem. 1993, 28, 517.
12. Ellis, G. P. In The Chemistry of Heterocyclic Compounds Chromenes, Chromanes
and Chromones; Weissberger, A., Taylor, E. C., Eds.; John Wiley: New York, NY,
1977; p 11. Chapter II.
13. Arnesto, D.; Horspool, W. M.; Martin, N.; Ramos, A.; Seaone, C. J. Org. Chem.
1989, 54, 3069.
Supplementary data
14. (a) Khurana, J. M.; Nand, B.; Saluja, P. Tetrahedron 2010, 66, 5637; (b) Khurana,
J. M.; Kumar, S. Tetrahedron Lett. 2009, 50, 4125; (c) Heravi, M. M.; Sadjadi, S.;
Haj, N. M.; Oskooie, H. A.; Bamoharram, F. F. Catal. Commun. 2009, 10, 1643.
and references therein; (d) Abdolmohammadi, S.; Balalaie, S. Tetrahedron Lett.
2007, 48, 3299.
Supplementary data (X-ray crystallographic data (CIF files) of 4a
and 4l and spectral data of all compounds and copies of 1H and 13
C
NMR spectra of products) associated with this article can be found,
15. General procedure for the synthesis of pyran annulated heterocyclic compounds:
Into a mixture of an aromatic aldehyde (1 mmol) and ethyl cyanoacetate or
malononitrile (1 mmol) in 4 mL of ethanol was added the catalyst DMAP
(0.025 g, 0.2 mmol) and kept for stirring at room temperature. The solid
precipitate was formed immediately in case of malononitrile or it took 20–
30 min. for ethyl cyanoacetate. Then C–H activated acidic compound (1 mmol)
was added into the reaction mixture and it was kept for stirring under reflux
conditions. After sometime, the reaction mixture was converted into clear
solution. After the completion of the reaction, the solid precipitate came out
under hot conditions at the stipulated time mentioned in the Table 2 and Table
3. The reaction mixture was brought to room temperature and the solid
precipitate was filtered off to obtain the desired product. Ethyl 2-amino-4-(3-
hydroxyphenyl)-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carboxylate Ethyl 2-
amino-7,7-dimethyl-5-oxo-4-phenyl-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate
References and notes
1. (a) Zhu, J.; Bienayme, H. Multicomponent Reactions, 1st ed.; Wiley-VCH:
Weinheim, Germany, 2005; (b) Dömling, A. Chem. Rev. 2006, 106, 17; (c) Zhu,
J. Eur. J. Org. Chem. 2003, 1133; (d) Dömling, A.; Ugi, I. Angew. Chem., Int. Ed.
2000, 39, 3168.
2. Wang, X.-S.; Li, Q.; Wu, J.-R.; Li, Y.-L.; Yao, C.-S.; Tu, S.-J. Synthesis 2008, 1902.
3. (a) Khan, A. T.; Khan, M. M.; Bannuru, K. K. R. Tetrahedron 2010, 66, 7762; (b)
Khan, A. T.; Khan, M. M. Tetrahedron Lett. 2011, 52, 3455; (c) Khan, A. T.; Lal, M.;
Khan, M. M. Tetrahedron Lett. 2010, 51, 4419; (d) Khan, A. T.; Parvin, T.;
Choudhury, L. H. J. Org. Chem. 2008, 73, 8398.
(4l): Yield 0.320 g, 94%. Solid, mp 144–146 °C. IR
mmax (KBr): 3403, 3290, 2956,
1667, 1614, 1524, 1371 cmÀ1 1H NMR (400 MHz, CDCl3): d 0.97 (s, 3H), 1.10 (s,
.
4. Murugan, R.; Sriven, E. F. V. Aldrichimica Acta 2003, 36, 21.
3H), 1.16 (t, J = 7.2 Hz, 3H), 2.19 (q, J = 16.4 Hz, 2H), 2.42 (s, 2H), 3.98-4.07 (m,
2H), 4.70 (s, 1H), 6.17 (brs, 2H), 7.10 (t, J = 7.2 Hz, 1H), 7.20 (t, J = 7.6 Hz, 2H),
7.26 (d, J = 7.2 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 14.4, 27.5, 29.2, 32.4, 33.9,
40.8, 50.9, 59.8, 80.9, 116.9, 126.2, 127.9, 128.4, 145.9, 158.5, 161.5, 169.3,
196.5 ; Anal. Calcd for C20H23NO4 (341.40): C, 70.36; H, 6.79; N, 4.10. Found C,
70.29; H, 6.71; N, 4.01.
5. (a) Dean, F. M. Naturally Occurring Oxygen Ring Compounds; Butter-worths:
London, 1963; (b) Feuer, G. Progress in Medicinal Chemistry In Ellis, G. P., West,
G. P., Eds.; North-Holland Publishing Company: New York, 1974.
6. Bonsignore, L.; Loy, G.; Secci, D.; Calignano, A. Eur. J. Med. Chem. 1993, 28, 517.
7. Cingolani, G. M.; Gualtteri, F.; Pigin, M. J. Med. Chem. 1961, 12, 531.
8. Wu, J. Y. C.; Fong, W. F.; Zhang, J. X.; Leung, C. H.; Kwong, H. L.; Yang, M. S.; Li,
D.; Cheung, H. Y. Eur. J. Pharmacol. 2003, 473, 9.
9. (a) Baraldi, P. G.; Manfredini, S.; Simoni, D.; Tabrizi, M. A.; Balzarini, J.; Clercq, E.
D. J. Med. Chem. 1877, 35, 1992; (b) Perrella, F. W.; Chen, S. F.; Behrens, D. L.;
Kaltenbach, R. F.; Seitz, S. P. J. Med. Chem. 1994, 37, 2232.
16. Complete crystallographic data of 4l for the structural analysis have been
deposited with the Cambridge Crystallographic Data Centre, CCDC No. 828132,
respectively. Copies of this information may be obtained free of charge from
the Director, Cambridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK, (fax: +44-1223-336033, e-mail: deposit@ccdc.
10. (a) Kashman, Y.; Gustafson, K. R.; Fuller, R. W.; Cardellina, J. H.; McMahon, J. B.;
Currens, M. J.; Buckheit, R. W.; Hughes, S. H.; Gragg, G. M.; Boyd, M. R. J. Med.